We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLYVK:NASDAQLiberty Live Holdings, Inc. - Series C Liberty Live Group Analysis

Data as of 2026-04-15 - not real-time

$101.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades at $101, comfortably above the 20‑day ($95.49), 50‑day ($94.07) and 200‑day ($89.08) SMAs, with a bullish MACD crossover (line 1.77 vs signal 1.14) and an RSI of 59.9 indicating room for upside. Support sits near $87.9 and resistance near $102.0, while volume is declining and 30‑day volatility is a lofty 40.5%, suggesting price swings may be sharp. The beta of ~0.93 and a Fear‑Greed Index of 88.6 (“Extreme Greed”) point to a market‑driven rally.
Fundamental backdrop: Revenue grew 29% to $381.9 M, yet operating margins are negative (‑11.2%) and earnings per share remain in the red (‑$0.96). Forward EPS of $1.28 hints at a turnaround, but a forward P/E of 78.9, price‑to‑sales of 24.3 and a negative book value (‑$0.53 per share) underscore severe overvaluation. The balance sheet is weighted toward debt ($1.67 B) versus cash ($545 M), and the recent $1.1 B senior debenture exchange adds refinancing risk. With no dividend and a single analyst target of $115 (≈14% upside), the stock appears expensive relative to its earnings and cash‑flow profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical positioning above key moving averages
  • High short‑term volatility and decreasing volume
  • Debt‑exchange news creating near‑term uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth but persistent negative operating margins
  • Forward EPS improvement versus current losses
  • Elevated forward P/E and price‑to‑sales ratios

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Heavy debt load relative to cash and negative equity
  • Overvaluation metrics far above industry averages
  • Unclear path to sustainable profitability despite growth hints

Key Metrics & Analysis

Financial Health

Revenue Growth29.00%
Profit Margin-22.77%
P/E Ratio78.9
ROA-1.86%
P/B Ratio-189.1
Op. Cash Flow$-29455000
Free Cash Flow$9.3M
Industry P/E18.9

Technical Analysis

TrendBullish
RSI59.9
Support$87.89
Resistance$102.05
MA 20$95.49
MA 50$94.07
MA 200$89.08
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64

Valuation

Target Price$115.00
Upside/Downside13.86%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.93
Volatility40.53%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.